Drugs / 0.9% Sodium Chloride Injection
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04365010 Comparator | May 2020 → Sep 2021 | infectious disease with sepsis | Southeast University, China | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 0.9% Sodium Chloride Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04365010 ↗ |
| Route | Intravenous | “Intravenous infusion” NCT04365010 ↗ |